These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34544099)

  • 21. Which patients should receive the herpes zoster vaccine?
    Short MD; Fergus C
    JAAPA; 2019 Sep; 32(9):18-20. PubMed ID: 31460969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Zoster disease after Shingrix vaccination].
    Kohn D; Wetzig T
    Hautarzt; 2021 Aug; 72(8):729-732. PubMed ID: 33294953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies with herpes zoster vaccines in immune compromised patients.
    Levin MJ; Bresnitz E; Popmihajlov Z; Weinberg A; Liaw KL; Willis E; Curtis JR
    Expert Rev Vaccines; 2017 Dec; 16(12):1217-1230. PubMed ID: 29053937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
    Lal H; Cunningham AL; Godeaux O; Chlibek R; Diez-Domingo J; Hwang SJ; Levin MJ; McElhaney JE; Poder A; Puig-Barberà J; Vesikari T; Watanabe D; Weckx L; Zahaf T; Heineman TC;
    N Engl J Med; 2015 May; 372(22):2087-96. PubMed ID: 25916341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
    Dagnew AF; Ilhan O; Lee WS; Woszczyk D; Kwak JY; Bowcock S; Sohn SK; Rodriguez Macías G; Chiou TJ; Quiel D; Aoun M; Navarro Matilla MB; de la Serna J; Milliken S; Murphy J; McNeil SA; Salaun B; Di Paolo E; Campora L; López-Fauqued M; El Idrissi M; Schuind A; Heineman TC; Van den Steen P; Oostvogels L;
    Lancet Infect Dis; 2019 Sep; 19(9):988-1000. PubMed ID: 31399377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes zoster vaccine. Poorly effective in those who need it most.
    Prescrire Int; 2012 Dec; 21(133):291. PubMed ID: 23373094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
    Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
    Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
    Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF
    J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella Virus Vaccination in the United States.
    Shaw J; Gershon AA
    Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should I get the shingles vaccine?
    Iverson K
    JAAPA; 2007 Jul; 20(7):55. PubMed ID: 17695099
    [No Abstract]   [Full Text] [Related]  

  • 32. Herpes zoster subunit vaccine for the prevention of herpes zoster.
    Symoniak MR; Farrokh P; Gandhi MA; Slish JC
    Am J Health Syst Pharm; 2018 Jun; 75(12):861-869. PubMed ID: 29880523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
    Chlibek R; Bayas JM; Collins H; de la Pinta ML; Ledent E; Mols JF; Heineman TC
    J Infect Dis; 2013 Dec; 208(12):1953-61. PubMed ID: 23904292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine profile of herpes zoster (HZ/su) subunit vaccine.
    Cunningham AL; Heineman T
    Expert Rev Vaccines; 2017 Jul; 16(7):1-10. PubMed ID: 28486850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
    Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
    J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella vaccination in the immunocompromised.
    Malaiya R; Patel S; Snowden N; Leventis P
    Rheumatology (Oxford); 2015 Apr; 54(4):567-9. PubMed ID: 24758889
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study.
    Lal H; Poder A; Campora L; Geeraerts B; Oostvogels L; Vanden Abeele C; Heineman TC
    Vaccine; 2018 Jan; 36(1):148-154. PubMed ID: 29174683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-clinical safety assessment of single and repeated administration of gE/AS01 zoster vaccine in rabbits.
    Giordano G; Segal L; Prinsen M; Wijnands MV; Garçon N; Destexhe E
    J Appl Toxicol; 2017 Feb; 37(2):132-141. PubMed ID: 27172098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient information. Should I get the shingles vaccine?
    JAAPA; 2007 Jul; 20(7):56. PubMed ID: 17695100
    [No Abstract]   [Full Text] [Related]  

  • 40. By the way, doctor. I'm 67 and had shingles four years ago. Am I immune to it now? If not, should I get the new shingles vaccine?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Oct; 15(2):8. PubMed ID: 18240445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.